403 related articles for article (PubMed ID: 25871629)
1. Longitudinal monitoring of metabolic alterations in cuprizone mouse model of multiple sclerosis using 1H-magnetic resonance spectroscopy.
Orije J; Kara F; Guglielmetti C; Praet J; Van der Linden A; Ponsaerts P; Verhoye M
Neuroimage; 2015 Jul; 114():128-35. PubMed ID: 25871629
[TBL] [Abstract][Full Text] [Related]
2. 17β-Estradiol enhances the efficacy of adipose-derived mesenchymal stem cells on remyelination in mouse model of multiple sclerosis.
Ragerdi Kashani I; Hedayatpour A; Pasbakhsh P; Kafami L; Atlasi N; Pirhajati Mahabadi V; Mamoudi R; Baazm M
Acta Med Iran; 2012; 50(12):789-97. PubMed ID: 23456519
[TBL] [Abstract][Full Text] [Related]
3. Multimodal imaging of subventricular zone neural stem/progenitor cells in the cuprizone mouse model reveals increased neurogenic potential for the olfactory bulb pathway, but no contribution to remyelination of the corpus callosum.
Guglielmetti C; Praet J; Rangarajan JR; Vreys R; De Vocht N; Maes F; Verhoye M; Ponsaerts P; Van der Linden A
Neuroimage; 2014 Feb; 86():99-110. PubMed ID: 23933305
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin F2α FP receptor inhibitor reduces demyelination and motor dysfunction in a cuprizone-induced multiple sclerosis mouse model.
Iwasa K; Yamamoto S; Takahashi M; Suzuki S; Yagishita S; Awaji T; Maruyama K; Yoshikawa K
Prostaglandins Leukot Essent Fatty Acids; 2014 Nov; 91(5):175-82. PubMed ID: 25224839
[TBL] [Abstract][Full Text] [Related]
5. Cuprizone-induced demyelination and demyelination-associated inflammation result in different proton magnetic resonance metabolite spectra.
Praet J; Orije J; Kara F; Guglielmetti C; Santermans E; Daans J; Hens N; Verhoye M; Berneman Z; Ponsaerts P; Van der Linden A
NMR Biomed; 2015 Apr; 28(4):505-13. PubMed ID: 25802215
[TBL] [Abstract][Full Text] [Related]
6. Quantitative MRI and ultrastructural examination of the cuprizone mouse model of demyelination.
Thiessen JD; Zhang Y; Zhang H; Wang L; Buist R; Del Bigio MR; Kong J; Li XM; Martin M
NMR Biomed; 2013 Nov; 26(11):1562-81. PubMed ID: 23943390
[TBL] [Abstract][Full Text] [Related]
7. G-Protein-Coupled Receptor Gpr17 Expression in Two Multiple Sclerosis Remyelination Models.
Nyamoya S; Leopold P; Becker B; Beyer C; Hustadt F; Schmitz C; Michel A; Kipp M
Mol Neurobiol; 2019 Feb; 56(2):1109-1123. PubMed ID: 29873041
[TBL] [Abstract][Full Text] [Related]
8. Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.
Acs P; Komoly S
Ideggyogy Sz; 2012 Jul; 65(7-8):266-70. PubMed ID: 23074847
[TBL] [Abstract][Full Text] [Related]
9. The cuprizone model: regional heterogeneity of pathology.
Wergeland S; Torkildsen Ø; Myhr KM; Mørk SJ; Bø L
APMIS; 2012 Aug; 120(8):648-57. PubMed ID: 22779688
[TBL] [Abstract][Full Text] [Related]
10. Demyelination increases radial diffusivity in corpus callosum of mouse brain.
Song SK; Yoshino J; Le TQ; Lin SJ; Sun SW; Cross AH; Armstrong RC
Neuroimage; 2005 May; 26(1):132-40. PubMed ID: 15862213
[TBL] [Abstract][Full Text] [Related]
11. Coenzyme Q10 enhances remyelination and regulate inflammation effects of cuprizone in corpus callosum of chronic model of multiple sclerosis.
Khalilian B; Madadi S; Fattahi N; Abouhamzeh B
J Mol Histol; 2021 Feb; 52(1):125-134. PubMed ID: 33245472
[TBL] [Abstract][Full Text] [Related]
12. Remyelination protects axons from demyelination-associated axon degeneration.
Irvine KA; Blakemore WF
Brain; 2008 Jun; 131(Pt 6):1464-77. PubMed ID: 18490361
[TBL] [Abstract][Full Text] [Related]
13. Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination.
Tanaka T; Murakami K; Bando Y; Yoshida S
J Neurochem; 2013 Oct; 127(2):259-70. PubMed ID: 23647102
[TBL] [Abstract][Full Text] [Related]
14. Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum after Cuprizone-Induced Demyelination.
Butti E; Bacigaluppi M; Chaabane L; Ruffini F; Brambilla E; Berera G; Montonati C; Quattrini A; Martino G
J Neurosci; 2019 Jul; 39(28):5481-5492. PubMed ID: 31138656
[TBL] [Abstract][Full Text] [Related]
15. PET imaging of demyelination and remyelination in the cuprizone mouse model for multiple sclerosis: a comparison between [11C]CIC and [11C]MeDAS.
de Paula Faria D; de Vries EF; Sijbesma JW; Dierckx RA; Buchpiguel CA; Copray S
Neuroimage; 2014 Feb; 87():395-402. PubMed ID: 24188813
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol Promotes Remyelination in Cuprizone Model of Multiple Sclerosis: Biochemical and Histological Study.
Ghaiad HR; Nooh MM; El-Sawalhi MM; Shaheen AA
Mol Neurobiol; 2017 Jul; 54(5):3219-3229. PubMed ID: 27067589
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum.
Sun SW; Liang HF; Trinkaus K; Cross AH; Armstrong RC; Song SK
Magn Reson Med; 2006 Feb; 55(2):302-8. PubMed ID: 16408263
[TBL] [Abstract][Full Text] [Related]
18. In vivo quantification of demyelination and recovery using compartment-specific diffusion MRI metrics validated by electron microscopy.
Jelescu IO; Zurek M; Winters KV; Veraart J; Rajaratnam A; Kim NS; Babb JS; Shepherd TM; Novikov DS; Kim SG; Fieremans E
Neuroimage; 2016 May; 132():104-114. PubMed ID: 26876473
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase-5 inhibition promotes remyelination by MCP-1/CCR-2 and MMP-9 regulation in a cuprizone-induced demyelination model.
Nunes AK; Rapôso C; de Oliveira WH; Thomé R; Verinaud L; Tovar-Moll F; Peixoto CA
Exp Neurol; 2016 Jan; 275 Pt 1():143-53. PubMed ID: 26515692
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells do not exert direct beneficial effects on CNS remyelination in the absence of the peripheral immune system.
Salinas Tejedor L; Berner G; Jacobsen K; Gudi V; Jungwirth N; Hansmann F; Gingele S; Prajeeth CK; Baumgärtner W; Hoffmann A; Skripuletz T; Stangel M
Brain Behav Immun; 2015 Nov; 50():155-165. PubMed ID: 26140734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
